How to Use Drug Sales Data to Refine Your Channel Strategy and Improve Your Portfolio Management
Historic drug sales data can help with market sizing. By examining sales trends over time you can gauge the attractiveness […]
Historic drug sales data can help with market sizing. By examining sales trends over time you can gauge the attractiveness […]
In evaluating generic entry opportunities many factors must be considered. DrugPatentWatch has comprehensive resources to aid in evaluating patent and
How to Use Drug Price Data for Generic Entry Portfolio Management and Prioritization Read Post »
The generic pharmaceutical industry exists at the intersection of business, science, law, and government regulation. To be perform well in
Generic Pharmaceutical Patent and FDA Law covers Food and Drug Administration approval of generic drugs and the interaction of patents
This article was originally published by Philippe Lahorte in World Patent Information Volume 54, Supplement, September 2018, Pages S18-S22 Under
We thought you might be interested in some of the great reviews we’re getting over at software review site G2Crowd.
See What Others are Saying About DrugPatentWatch Read Post »
DrugPatentWatch, a provider of global biopharmaceutical business intelligence, has entered into a partnership with Adis. The partner will enhance Adis’
DrugPatentWatch Partners with Adis: Helping Drug Companies Make Better Decisions Read Post »
Branded generics are generic drugs that have been given proprietary brand names. They have a small, but profitable place in the U.S. pharmaceutical market.
Branded Generics: What They Are and Why They’re Profitable Read Post »
Kenneth L. Dorsney, Editor-in-Chief 1,035 pages Buy from Amazon Pre-ANDA litigation is the companion to ANDA Litigation, which I recommend
Get fresh news and insights, drug patent expirations & more…